Average Co-Inventor Count = 6.87
ph-index = 4
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Incyte Corporation (5 from 665 patents)
2. Bristol-myers Squibb Compnay (3 from 3,684 patents)
3. Bristol-myers Squibb Pharma Company (3 from 234 patents)
11 patents:
1. 9067921 - Piperazinylpiperidine derivatives as chemokine receptor antagonists
2. 8680104 - Piperazinylpiperidine derivatives as chemokine receptor antagonists
3. 8268826 - Piperazinylpiperidine derivatives as chemokine receptor antagonists
4. 7998959 - Modulators of 11-β hydroxyl steroid dehydrogenase type 1, pharmaceutical compositions thereof, and methods of using the same
5. 7678798 - Piperazinylpiperidine derivatives as chemokine receptor antagonists
6. 7595317 - Barbituric acid derivatives as inhibitors of TNF-α converting enzyme (TACE) and/or matrix metalloproteinases
7. 7294624 - Barbituric acid derivatives as inhibitors of TNF-α converting enzyme (TACE) and/or matrix metalloproteinases
8. 7132432 - Hydantoin derivatives as inhibitors of tumor necrosis factor-alpha converting enzyme (TACE)
9. 6984648 - Cyclic β-amino acid derivatives as inhibitors of matrix metalloproteases and TNF-α
10. 6743807 - Cyclic &bgr;-amino acid derivatives as inhibitors of matrix metalloproteases and TNF-&agr;
11. 6455522 - Cyclic sulfonamide derivatives as metalloproteinase inhibitors